Lifestyle Modification in the Treatment of NAFLD.

Recruiting N/A Interventional Study
NAFLD
No Placebo Group Every participant receives an active treatment — no one gets a placebo.
Ready to participate?

Review the details below, then apply to join this clinical trial.

At a Glance
Age
18 and older
Sex
Any
Study type
Interventional
Purpose
Treatment
Participants needed
100 (estimated)
Sponsor
General University Hospital, Prague · Other
Think this trial could be right for you?

Answer a few quick questions to see if you may meet the eligibility requirements.

Check Your Eligibility
About This Trial

The project will study the impact of individually tailored lifestyle counselling compared to standard care on the parameters of NAFLD/NASH in patients with metabolic syndrome. The factors affecting the outcome (including clinical and laboratory parameters and microbiome profiling) will be evaluated.

Trial Locations
Loading…

Loading trial locations…

Eligibility Criteria
Inclusion Criteria: * Individuals with NAFLD and metabolic syndrome Exclusion Criteria: * Etiology of liver disease other than NAFLD. * Presence of malignant disease. * Uncontrolled cardiovascular disease * Pregnancy.
Contacts

Radan Bruha, Prof.

+420224962506

bruha@cesnet.cz

CONTACT

Vaclav Smid, MD

+420224962506

vaclav.smid@vfn.cz

CONTACT